NHAS
KNTE
Novo Holdings A/S’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-815,707
| Closed | -$1.14M | – | 41 |
|
|
2023
Q3 | $1.14M | Hold |
815,707
| – | – | 0.08% | 39 |
|
|
2023
Q2 | $2.47M | Hold |
815,707
| – | – | 0.19% | 39 |
|
|
2023
Q1 | $5.1M | Hold |
815,707
| – | – | 0.34% | 42 |
|
|
2022
Q4 | $4.98M | Hold |
815,707
| – | – | 0.31% | 42 |
|
|
2022
Q3 | $9.75M | Hold |
815,707
| – | – | 0.46% | 38 |
|
|
2022
Q2 | $10.3M | Buy |
815,707
+191,471
| +31% | +$2.41M | 0.51% | 36 |
|
|
2022
Q1 | $7.03M | Buy |
624,236
+71,108
| +13% | +$801K | 0.37% | 40 |
|
|
2021
Q4 | $9.8M | Buy |
553,128
+54,600
| +11% | +$967K | 0.46% | 31 |
|
|
2021
Q3 | $11.5M | Buy |
498,528
+198,528
| +66% | +$4.57M | 0.59% | 28 |
|
|
2021
Q2 | $6.98M | Hold |
300,000
| – | – | 0.31% | 44 |
|
|
2021
Q1 | $9.35M | Hold |
300,000
| – | – | 0.39% | 34 |
|
|
2020
Q4 | $11.9M | Buy |
+300,000
| New | +$11.9M | 0.51% | 31 |
|